Product

ZM-01-L

Aliases

rAAV-hRS1

1 clinical trial

1 indication

Indication

X-linked retinoschisis

Clinical trial

Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-01 in 3-18 Year-old Male Subjects With X-linked Retinoschisis

Status: Recruiting, Estimated PCD: 2023-10-31